These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34031649)

  • 1. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
    Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
    Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.
    Yokota I; Shane PY; Teshima T
    Travel Med Infect Dis; 2021; 43():102127. PubMed ID: 34174408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19.
    Asai N; Sakanashi D; Ohashi W; Nakamura A; Kawamoto Y; Miyazaki N; Ohno T; Yamada A; Chida S; Shibata Y; Kato H; Shiota A; Hagihara M; Koita I; Yamagishi Y; Suematsu H; Ohta H; Mikamo H
    J Infect Chemother; 2021 Jul; 27(7):1039-1042. PubMed ID: 33840598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
    Basso D; Aita A; Padoan A; Cosma C; Navaglia F; Moz S; Contran N; Zambon CF; Maria Cattelan A; Plebani M
    Clin Chim Acta; 2021 Jun; 517():54-59. PubMed ID: 33626369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of RT-qPCR test for SARS-CoV-2 in saliva specimens.
    Ávila LMS; Galvis MLD; Campos MAJ; Lozano-Parra A; Villamizar LAR; Arenas MO; Martínez-Vega RA; Cala LMV; Bautista LE
    J Infect Public Health; 2022 Dec; 15(12):1403-1408. PubMed ID: 36371937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of saliva and nasopharyngeal swab for SARS-CoV-2 detection using RT-qPCR among COVID-19 suspected patients at Jigjiga, Eastern Ethiopia.
    Tahir B; Weldegebreal F; Ayele F; Ayana DA
    PLoS One; 2023; 18(3):e0282976. PubMed ID: 36913377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Qualitative and Quantitative Antigen Tests for SARS-CoV-2 Using Saliva.
    Yokota I; Sakurazawa T; Sugita J; Iwasaki S; Yasuda K; Yamashita N; Fujisawa S; Nishida M; Konno S; Teshima T
    Infect Dis Rep; 2021 Aug; 13(3):742-747. PubMed ID: 34449650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals.
    Castillo-Bravo R; Lucca N; Lai L; Marlborough K; Brychkova G; Sakhteh MS; Lonergan C; O'Grady J; Alikhan NF; Trotter AJ; Page AJ; Smyth B; McKeown PC; Feenstra JDM; Ulekleiv C; Sorel O; Gandhi M; Spillane C
    Microbiol Spectr; 2022 Dec; 10(6):e0222922. PubMed ID: 36409097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance.
    Aita A; Navaglia F; Moz S; Contran N; Barbaro F; Cattelan AM; Padoan A; Cosma C; Faggian D; Plebani M; Basso D
    Clin Chem Lab Med; 2023 Jan; 61(2):323-331. PubMed ID: 36282616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Real-Time Polymerase Chain Reaction in COVID-19 Patients.
    Lawrence Panchali MJ; Oh HJ; Lee YM; Kim CM; Tariq M; Seo JW; Kim DY; Yun NR; Kim DM
    Microbiol Spectr; 2022 Feb; 10(1):e0059121. PubMed ID: 35170995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR.
    Chomczynski P; Chomczynski PW; Kennedy A; Rymaszewski M; Wilfinger WW; Heiny JA; Mackey K
    PLoS One; 2021; 16(2):e0246867. PubMed ID: 33566873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive SARS-CoV-2 detection, air travel Covid-19 testing, variant determination and fast direct PCR detection, using ddPCR and RT-qPCR methods.
    Burjanivova T; Lukacova E; Lucansky V; Samec M; Podlesniy P; Kolkova Z; Reizigova L; Grendar M; Turyova E; Holubekova V; Malicherova B; Nosal V; Kasubova I; Dusenka R; Osinova D; Hosalova Matisova J; Dvorska D; Brany D; Dankova Z; Novakova E; Calkovska A; Halasova E
    Acta Virol; 2023; 67(1):3-12. PubMed ID: 36876506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.